Korea is tired of watching biohealth breakthroughs stall in the lab. With four out of five high-risk R&D projects failing to ...

Celltrion has shifted to a direct sales model in Spain, ending its final indirect sales partnership among Europe’s five ...

A lawmaker has proposed a bill to shorten the mandatory service period for public health doctors and military doctors from ...

Cosmax posted record quarterly sales of 588.6 billion won and an operating profit of 51.3 billion won in the first quarter of ...

Dong-A ST said Wednesday it signed a business agreement with Korean medical AI company Mediwhale to distribute its AI-powered ...

Korea’s health professionals are voicing growing concern over delayed reimbursement for innovative drugs, calling for faster ...

Ainex Corporation said Wednesday that its AI-powered colorectal cancer imaging detection and diagnostic support software, ...

GSK is preparing to introduce its respiratory syncytial virus (RSV) vaccine, Arexvy, to the Korean market by the end of May.

Despite a challenging investment climate, South Korea-based Pin Therapeutics has drawn significant funding and is moving ...

GC Biopharma said Wednesday that the U.S. FDA has approved its sixth plasma collection center -- this time in Calexico, ...

Korean pharmaceutical firm Huons said Wednesday it expects minimal impact from a recent executive order signed by U.S.

Curocell said Tuesday that its CAR-T therapy for solid tumors, currently being developed in collaboration with Seoul National ...